Finance

Lists
Why is REVB down 5.81%?
Dive Deeper
REVB:NASDAQ
Revelation Biosciences Inc
$0.78
-5.81%
(-0.048) 1D
$0.77
-1.28% (-0.0100)
After hours
Closed: Oct 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for REVB...
Open
$0.81
High
$0.81
Low
$0.77
Mkt. cap
3.10M
Avg. vol.
30.82K
Volume
13.00
52-wk high
$6.76
52-wk low
$0.75
EPS
-$12.29
Beta
-0.07
Shares outstanding
3.98M
No. of employees
8
Open
$0.81
High
$0.81
Low
$0.77
Mkt. cap
3.10M
Avg. vol.
30.82K
Volume
13.00
52-wk high
$6.76
52-wk low
$0.75
EPS
-$12.29
Beta
-0.07
Shares outstanding
3.98M
No. of employees
8
News stories
From web sources and news partners
About Revelation Biosciences Inc
CEO-
Employees8
Founded2019
Headquarters-
SectorBiotechnology
Websiterevbiosciences.com
Analyst ratings
Based on 1 analyst giving stock ratings to REVB in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for REVB in the last 3 months
Highest
Current $0.78
$16.00 (+1,951.28%)
Average
$16.00 (+1,951.28%)
Lowest
$16.00 (+1,951.28%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Aschoff
Roth MKM
Buy
Maintained
$16.00
+1,951.3%
08/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
922.86K
964.19K
1.38M
1.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.02M
1.61M
1.72M
1.74M
Operating expense
1.94M
2.57M
3.09M
3.66M
Total operating expenses
1.94M
2.57M
3.09M
3.66M
Operating income
-1.94M
-2.57M
-3.09M
-3.66M
Other non operating income
35.84K
60.58K
83.45K
338.86K
EBT including unusual items
-1.91M
-2.51M
-3.01M
-3.32M
EBT excluding unusual items
-1.91M
-2.51M
-3.01M
-3.32M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.91M
-2.51M
-3.01M
-3.32M
Net profit margin
-
-
-
-
Earnings per share
-7.08
-1.65
-2.71
-0.87
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.94M
-2.57M
-3.09M
-3.65M
Gain or loss from assets sale
4.49K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps